Theratechnologies

$3.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+3.55%) Today
+$0.09 (+2.80%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell THTX and other stocks, options, and ETFs commission-free!

About THTX

Theratechnologies Inc. Common Shares, also called Theratechnologies, is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada. The listed name for THTX is Theratechnologies Inc. Common Shares.

CEO
Paul Lévesque
Employees
112
Headquarters
Montréal, Québec
Founded
1993
Market Cap
286.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
686.12K
High Today
$3.25
Low Today
$2.99
Open Price
$3.09
Volume
734.99K
52 Week High
$3.25
52 Week Low
$1.33

THTX Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.07 per share

You May Also Like

BCAUY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure